Related Experiment Video
Updated: Aug 16, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Carney complex presenting as subclinical Cushing syndrome in a child due to a novel Phosphodiesterase 11A mutation
Qian Sun1, Jie Song1, Wenjing Feng1
1Departments of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Insights
Researchers identified a new PDE11A gene mutation causing Carney complex (CNC) in a Chinese family. This finding highlights the importance of genetic testing and managing associated conditions like Cushing's syndrome.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- Carney complex (CNC) is a rare genetic disorder associated with multiple endocrine neoplasia.
- Key genes implicated in CNC include PRKAR1A, PDE8B, and PDE11A.
Purpose of the Study:
- To characterize the clinical presentation of CNC in a Chinese patient.
- To identify pathogenic mutations contributing to CNC in a Chinese family.
Main Methods:
- Genomic DNA was isolated from peripheral blood of a Chinese CNC family.
- Targeted region sequencing (TRS) and Sanger sequencing were employed for mutation identification and validation.
Main Results:
- A novel PDE11A variant (NM_016953: exon11: c1921A>G, p.Lys641Glu) was identified and predicted to cause CNC.
- The identified mutation was also present in the patient's mother, suggesting familial inheritance.
Conclusions:
- This study reports a new genetic mutation in PDE11A associated with Carney complex.
- Early detection and management of subclinical Cushing's syndrome in CNC patients are crucial.
Background:
Several disease-causing genes have been implicated in Carney complex (CNC), including PRKAR1A, PDE8B(Phosphodiesterase 8B),and PDE11A (Phosphodiesterase 11A). The purpose of this study was to describe the clinical features of CNC in a Chinese patient and identify potential pathogenic mutations.
Methods:
Genomic DNA was extracted from the peripheral venous blood obtained from one Chinese CNC family from Shandong province. Subsequently, targeted region sequencing (TRS) and Sanger sequencing validation were performed to identify and validate likely pathogenic mutations.
Results:
Genetic analyses revealed a novel PDE11A variant that was predicted to lead to CNC. The patient's mother presented with the same genetic mutation.
Conclusion:
This study identifies new genetic mutation in CNC(PDE11A: NM_016953: exon11: c1921A>G (p./p.Lys641Glu). CNC patients presenting with subclinical Cushing's syndrome should be treated.
More Related Videos
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
GPCRs Regulate Adenylyl Cylase Activity
Abnormal Proliferation
cAMP-dependent Protein Kinase Pathways

